Physician profile
Caroline Adele Hamilton
NPI 1215472410
$1,443.61
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $499 · 2023: $633 · 2024: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $374.78 | 2021-2024 | |
| Melinta Therapeutics, LLC | $203.75 | 2021-2024 | Rezzayo, Vabomere, Kimyrsa |
| Shionogi INC | $144.43 | 2021-2024 | Fetroja |
| Merck Sharp & Dohme LLC | $139.43 | 2021-2024 | Delstrigo, Dificid, Pifeltro |
| Viiv Healthcare Company | $136.95 | 2021-2024 | Dovato, Rukobia |
| Insmed, INC. | $125.00 | 2023 | Arikayce |
| Janssen Biotech, INC. | $99.26 | 2021-2023 | Symtuza |
| Next Science LLC | $96.97 | 2022 | |
| Theratechnologies INC. | $69.30 | 2021-2022 | |
| Grifols USA, LLC | $20.86 | 2023 | Prolastin-C Liquid |
| La Jolla Pharmaceutical Company | $18.17 | 2023 | Xerava |
| Janssen Scientific Affairs, LLC | $14.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.